Director/Sr. Director, Regulatory Affairs San Francisco, CA/Hybrid
3 days ago
San Francisco
Calcilytix San Francisco, CA/Hybrid Regulatory Affairs
Calcilytix Therapeutics , an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a ...